Your recipients will receive an email with this envelope shortly and will be able to access it on trellis. You can always see your envelopes by clicking the Inbox on the top right hand corner.
Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Suc…
Torts - Asbestos case was filed by (Subcribe to view) represented by (Subcribe to view) against (Subscribe to view) represented by (Subscribe to view) in the jurisdiction of Erie County. Judge Raymond Walter presiding.
Case Details
Case Number
Filing Date
December 10, 2020
Last Refreshed
July 26, 2023
Filing Location
Erie County, NY
Judge
Hon. Raymond Walter
Category
Torts - Asbestos
Practice Area
Torts
Matter Type
Mass Torts
Status
Dismissal
Overview
Causes of Action
1. FOR NEGLIGENT FAILURE TO WARN AGAINST THE DEFENDANTS NAMED HEREIN, PLAINTIFF PATSY YOUNG ALLEGES:
2. FOR STRICT PRODUCTS LIABILITY AGAINST THE DEFENDANTS NAMED HERElN, PLAINTIFF PATSY YOUNG ALLEGES:
3. AGAINST THE DEFENDANTS NAMED HEREIN, PLAINTIFF PATSY YOUNG ALLEGES:
4. AGAINST THE DEFENDANTS NAMED HEREIN, PLAINTIFF PATSY YOUNG ALLEGES:
Parties
Plaintiffs
Patsy Young
Attorneys for Plaintiffs
Comerford, John P.
Kagan, Leah Cylia
Morton, Mathew John
Defendants
Aventis Inc.
Avon Products, Inc.
Block Drug Company, Inc.
Block Drug Corporation
Brenntag North America, Inc.
Brenntag Specialties, Inc. F K A Mineral Pigment Solutions, Inc.
Charles B. Chrystal Company, Inc.
Chattem, Inc.
Colgate-Palmolive Company
Cyprus Amax Minerals Company
Cyprus Mines Corporation
Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A K A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And
Novartis Consumer Health Inc.)
Gsk Consumer Health, Inc. F K A Novartis Consumer Health Inc. F K A Ciba Self-Medication, Inc.
Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc.
Insight Pharmaceuticals Llc
Macy'S Inc. F K A Federated Department Stores, Inc.
Novartis Pharmaceuticals Corporation
Prestige Brands Holdings, Inc.
Prestige Consumer Healthcare Inc. F K A Prestige Brands, Inc.
Sanofi-Aventis U.S. Llc
Sanofi Us Services, Inc.
Whittaker Clark & Daniels, Inc.
Attorneys for Defendants
Dimarco, Erik Christopher
Downey, Patrick F
Hanna, Sam Fahmy
Haque, Mohammad Muneeb
Herrscher, Mary Jo
Kozak, Christopher Stephen
Mahoney, Nancy
Mullins, Robert J
Naylon, Patrick Brennan
Novakidis, Stephen
Oxamendi, David
Ricci, Dana Marie
Rizvi, Syed Kazim
Ryan, Jodie L.
Sapon, Andrew
Seltzer, Whitney
Squitieri, Virginia Paula
Tempesta, Carol Maria
Van Gelder, Susan Elizabeth
Welter, Joseph J.
Case Documents
EXHIBIT(S) - 6
Date: Mar 17, 2023
EXHIBIT(S) - 8
Date: Mar 17, 2023
EXHIBIT(S) - 7
Date: Mar 17, 2023
AFFIDAVIT OR AFFIRMATION IN REPLY
Date: Mar 17, 2023
EXHIBIT(S) - 15
Date: Mar 17, 2023
MEMORANDUM OF LAW IN OPPOSITION
Date: Mar 17, 2023
EXHIBIT(S) - 2
Date: Mar 17, 2023
NOTICE OF MOTION FOR SUMMARY JUDGMENT IN LIEU OF COMPLAINT
Date: Mar 17, 2023
EXHIBIT(S) - 3
Date: Mar 17, 2023
EXHIBIT(S) - 120 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 142 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 111 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 114 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 130 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 117 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 134 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 132 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 146 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 158 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 104 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 116 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 136 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 121 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 144 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 131 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 108 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 145 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 112 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 141 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 123 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 113 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 143 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 109 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 115 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 140 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 139 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 163 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 127 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 129 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 137 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 135 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 125 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 126 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 106 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 107 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 138 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 122 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 105 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 128 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 155 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 133 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 159 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 162 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 32 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 34 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 16
Date: Mar 17, 2023
EXHIBIT(S) - 10
Date: Mar 17, 2023
EXHIBIT(S) - 73 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 9
Date: Mar 17, 2023
EXHIBIT(S) - 17
Date: Mar 17, 2023
EXHIBIT(S) - 11
Date: Mar 17, 2023
EXHIBIT(S) - 35 (Motion 003) Ex 35 LONGO DEC WITH EXHIBITS
Date: Mar 17, 2023
EXHIBIT(S) - 24
Date: Mar 17, 2023
EXHIBIT(S) - 30
Date: Mar 17, 2023
EXHIBIT(S) - 27
Date: Mar 17, 2023
EXHIBIT(S) - 18
Date: Mar 17, 2023
EXHIBIT(S) - 28
Date: Mar 17, 2023
EXHIBIT(S) - 29
Date: Mar 17, 2023
EXHIBIT(S) - 12
Date: Mar 17, 2023
EXHIBIT(S) - 20
Date: Mar 17, 2023
EXHIBIT(S) - 22
Date: Mar 17, 2023
EXHIBIT(S) - 25
Date: Mar 17, 2023
EXHIBIT(S) - 21
Date: Mar 17, 2023
EXHIBIT(S) - 13
Date: Mar 17, 2023
EXHIBIT(S) - 26
Date: Mar 17, 2023
EXHIBIT(S) - 23
Date: Mar 17, 2023
EXHIBIT(S) - 14
Date: Mar 17, 2023
EXHIBIT(S) - 49 (Motion 003)
Date: Mar 17, 2023
AFFIRMATION
Date: Mar 17, 2023
EXHIBIT(S) - 80 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 62 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 48 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 50 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 71 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 79 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 63 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 51 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 74 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 52 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 65 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 81 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 72 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 64 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 75 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 76 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 86 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 99 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 82 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 84 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 83 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 53 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 78 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 77 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 100 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 85 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 87 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 54 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 94 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 56 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 88 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 98 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 55 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 96 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 97 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 90 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 89 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 92 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 95 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 93 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 91 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 102 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 57 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 103 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 110 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 101 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 160 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 157 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 151 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 156 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 4
Date: Mar 17, 2023
EXHIBIT(S) - 1
Date: Mar 17, 2023
EXHIBIT(S) - 5
Date: Mar 17, 2023
EXHIBIT(S) - 36 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 39 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 38 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 37 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 58 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 43 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 42 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 41 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 41 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 66 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 46 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 45 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 59 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 44 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 61 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 60 (Motion 003)
Date: Mar 17, 2023
STATEMENT OF MATERIAL FACTS
Date: Mar 17, 2023
EXHIBIT(S) - 69 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 68 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 67 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 70 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 147 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 154 (Motion 003)
Date: Mar 17, 2023
MEMORANDUM OF LAW IN REPLY
Date: Mar 17, 2023
EXHIBIT(S) - 118 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 47 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 148 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 119 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 153 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 152 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 149 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 150 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 161 (Motion 003)
Date: Mar 17, 2023
EXHIBIT(S) - 22 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 24 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 28 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 25 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 23 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 31 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 35 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 32 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 30 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 33 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 34 (Motion 003)
Date: Mar 03, 2023
NOTICE OF MOTION (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - 8 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 2 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 9 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - P (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - 7 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 6 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 5 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - O (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - 1 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - T (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - P (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - R (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - Q (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - L (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - N (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - S (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - H (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - V (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - U (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - HH (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - W (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - D (Motion 001)
Date: Mar 03, 2023
EXHIBIT(S) - A (Motion 001)
Date: Mar 03, 2023
EXHIBIT(S) - B (Motion 001)
Date: Mar 03, 2023
NOTICE OF MOTION (Motion 001)
Date: Mar 03, 2023
MEMORANDUM OF LAW IN SUPPORT
Date: Mar 03, 2023
EXHIBIT(S) - 21 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - A (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - 43 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - PP (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - 36 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - NN (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - 42 (Motion 003)
Date: Mar 03, 2023
AFFIDAVIT OR AFFIRMATION IN SUPPORT OF MOTION (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - 40 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 41 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 37 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - II (Motion 004)
Date: Mar 03, 2023
NOTICE OF MOTION (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - S (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - O (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - M (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - R (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - L (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - N (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - T (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - E (Motion 002)
Date: Mar 03, 2023
AFFIDAVIT OR AFFIRMATION IN SUPPORT OF MOTION
Date: Mar 03, 2023
EXHIBIT(S) - Q (Motion 002)
Date: Mar 03, 2023
NOTICE OF MOTION (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - C (Motion 001)
Date: Mar 03, 2023
AFFIDAVIT OR AFFIRMATION IN SUPPORT (Motion 002)
Date: Mar 03, 2023
AFFIDAVIT OR AFFIRMATION IN SUPPORT OF MOTION (Motion 001)
Date: Mar 03, 2023
MEMORANDUM OF LAW IN SUPPORT (Motion 001)
Date: Mar 03, 2023
EXHIBIT(S) - G (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - D (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - H (Motion 002)
Date: Mar 03, 2023
CERTIFICATION OF SIGNATURE ( ATTORNEY OR PARTY ) (Motion 001)
Date: Mar 03, 2023
EXHIBIT(S) - F (Motion 002)
Date: Mar 03, 2023
ORDER ( PROPOSED ) (Motion 001)
Date: Mar 03, 2023
EXHIBIT(S) - I (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - Y (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - LL (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - K (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - X (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - OO (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - 39 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - C (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - M (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - J (Motion 004)
Date: Mar 03, 2023
MEMORANDUM OF LAW IN SUPPORT (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - G (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - JJ (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - 38 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - Z (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - D (Motion 004)
Date: Mar 03, 2023
STATEMENT OF MATERIAL FACTS (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - CC (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - E (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - EE (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - DD (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - BB (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - B (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - KK (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - MM (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - F (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - FF (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - GG (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - AA (Motion 004)
Date: Mar 03, 2023
EXHIBIT(S) - J (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - 11 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 17 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - I (Motion 002)
Date: Mar 03, 2023
EXHIBIT(S) - 13 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 14 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 12 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 10 (Motion 003)
Date: Mar 03, 2023
STATEMENT OF MATERIAL FACTS
Date: Mar 03, 2023
EXHIBIT(S) - 15 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 19 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 26 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 16 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 18 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 29 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 20 (Motion 003)
Date: Mar 03, 2023
EXHIBIT(S) - 27 (Motion 003)
Date: Mar 03, 2023
ORDER - CASE SCHEDULING
Date: Feb 08, 2023
PRE-TRIAL DOCUMENT(S)
Date: Jan 31, 2023
ORDER ( PROPOSED ) Proposed 3rd Amended Scheduling Order, TD 5/23/2023
Date: Jan 27, 2023
NOTE OF ISSUE:WITH JURY
Date: Jan 18, 2023
ORDER - CASE SCHEDULING
Date: Oct 26, 2022
ORDER ( PROPOSED )
Date: Oct 13, 2022
STIPULATION - SO ORDERED
Date: Jul 28, 2022
STIPULATION - DISCOVERY ( REQUEST TO SO ORDER )
Date: Jul 18, 2022
STIPULATION - CONFIDENTIALITY ( REQUEST TO SO ORDER )
Date: Jul 14, 2022
STIPULATION - DISCONTINUANCE (POST RJI)
Date: Jun 24, 2022
NOTICE OF ENTRY
Date: Jun 13, 2022
NOTICE OF ENTRY
Date: Jun 13, 2022
NOTICE OF ENTRY
Date: Jun 13, 2022
ORDER - DISMISSAL
Date: Jun 11, 2022
ORDER - DISMISSAL
Date: Jun 11, 2022
ORDER - DISMISSAL
Date: Jun 11, 2022
ORDER ( PROPOSED )
Date: Jun 07, 2022
ORDER ( PROPOSED )
Date: Jun 07, 2022
ORDER ( PROPOSED )
Date: Jun 07, 2022
STIPULATION - PARTIAL DISCONTINUANCE (POST RJI)
Date: Jun 06, 2022
STIPULATION - PARTIAL DISCONTINUANCE (POST RJI)
Date: Jun 06, 2022
STIPULATION - PARTIAL DISCONTINUANCE (POST RJI)
Date: Jun 06, 2022
CONSENT TO CHANGE ATTORNEY (POST RJI)
Date: Apr 21, 2022
ORDER - TRIAL SCHEDULING
Date: Mar 23, 2022
EXHIBIT(S) - B
Date: Mar 23, 2022
EXHIBIT(S) - A
Date: Mar 23, 2022
PRE-TRIAL DOCUMENT(S)
Date: Jan 18, 2022
ORDER (PROPOSED) (AMENDED)
Date: Jan 13, 2022
EXHIBIT(S) - B
Date: Jan 13, 2022
EXHIBIT(S) - A
Date: Jan 13, 2022
ORDER - DISMISSAL
Date: Jan 03, 2022
NOTICE OF ENTRY
Date: Jan 03, 2022
EXHIBIT(S) - A
Date: Jan 03, 2022
LETTER / CORRESPONDENCE TO JUDGE
Date: Dec 22, 2021
STIPULATION - DISCONTINUANCE (POST RJI)
Date: Dec 22, 2021
ORDER ( PROPOSED )
Date: Dec 22, 2021
ANSWER WITH CROSS-CLAIM(S)
Date: Oct 18, 2021
AFFIDAVIT
Date: Sep 02, 2021
NOTICE OF ENTRY
Date: Aug 09, 2021
ORDER - DISMISSAL
Date: Aug 09, 2021
ORDER ( PROPOSED )
Date: Aug 04, 2021
NOTICE OF DEPOSITION UPON ORAL EXAMINATION
Date: Jul 26, 2021
AFFIDAVIT
Date: Jul 26, 2021
LETTER / CORRESPONDENCE TO JUDGE
Date: Jul 22, 2021
EXHIBIT(S) - A
Date: Jul 14, 2021
LETTER / CORRESPONDENCE TO JUDGE
Date: Jul 14, 2021
STIPULATION - DISCONTINUANCE (POST RJI)
Date: Jul 12, 2021
DEMAND FOR:
Date: Jun 23, 2021
THIRD PARTY SUMMONS/COMPLAINT
Date: Jun 17, 2021
ANSWER
Date: Mar 19, 2021
ANSWER
Date: Mar 19, 2021
ANSWER
Date: Mar 19, 2021
EXHIBIT(S) - A
Date: Mar 19, 2021
ORDER - TRIAL SCHEDULING
Date: Mar 19, 2021
ORDER ( PROPOSED )
Date: Mar 17, 2021
EXHIBIT(S) - A
Date: Mar 17, 2021
ANSWER
Date: Mar 04, 2021
ANSWER WITH CROSS-CLAIM(S)
Date: Mar 02, 2021
STIPULATION - DISCONTINUANCE (POST RJI)
Date: Mar 01, 2021
ANSWER WITH CROSS-CLAIM(S)
Date: Feb 18, 2021
NOTICE OF BANKRUPTCY (POST RJI)
Date: Feb 14, 2021
ANSWER
Date: Feb 12, 2021
ANSWER
Date: Feb 12, 2021
ANSWER
Date: Feb 12, 2021
ANSWER
Date: Feb 12, 2021
AFFIRMATION/AFFIDAVIT OF SERVICE
Date: Jan 26, 2021
DEMAND FOR:
Date: Jan 26, 2021
ANSWER WITH CROSS-CLAIM(S)
Date: Jan 26, 2021
ANSWER WITH CROSS-CLAIM(S)
Date: Jan 25, 2021
ANSWER WITH CROSS-CLAIM(S)
Date: Jan 12, 2021
ANSWER WITH CROSS-CLAIM(S)
Date: Jan 12, 2021
EXHIBIT(S) - A
Date: Dec 10, 2020
ADDENDUM - GENERAL (840A)
Date: Dec 10, 2020
RJI -RE: REQUEST FOR PRELIMINARY CONFERENCE
Date: Dec 10, 2020
SUMMONS COMPLAINT
Date: Dec 10, 2020Case Events
| Date | Type | Description | |
|---|---|---|---|
| March 17, 2023 |
EXHIBIT(S) - 6 1-23-15 Capdevielle Depo in Winkel |
||
| March 17, 2023 |
EXHIBIT(S) - 8 4-6-11 & 4-7-11 Ohlmeyer Depo in Bernard and Tedrick |
||
| March 17, 2023 |
EXHIBIT(S) - 7 10-27-10 Briscese Depo in Bernard and Tedrick |
||
| March 17, 2023 | AFFIDAVIT OR AFFIRMATION IN REPLY | ||
| March 17, 2023 |
EXHIBIT(S) - 15 Ex 15 - 12-2-10 Simko Depo in NY Asb Lit |
||
| March 17, 2023 | MEMORANDUM OF LAW IN OPPOSITION | ||
| March 17, 2023 |
EXHIBIT(S) - 2 Young DBE |
||
| March 17, 2023 | NOTICE OF MOTION FOR SUMMARY JUDGMENT IN LIEU OF COMPLAINT | ||
| March 17, 2023 |
EXHIBIT(S) - 3 Colgate Resp to First |
||
| March 17, 2023 |
EXHIBIT(S) - 120 (Motion #003) Ex 120 - Consumer Talcums and Powders Mineral and Chem Characterization Rohl, et al 1976 |
||
| March 17, 2023 |
EXHIBIT(S) - 142 (Motion #003) Ex 142 - 2023 Moline et al |
||
| March 17, 2023 |
EXHIBIT(S) - 111 (Motion #003) Ex 111 - RJL Yellowstone Testing Tremolite Asb |
||
| March 17, 2023 |
EXHIBIT(S) - 114 (Motion #003) Ex 114 - A Textbook of Mineralogy - Dana 1932 |
||
| March 17, 2023 |
EXHIBIT(S) - 124 (Motion #003) Ex 124 - 3-3-17 Malignant Meso Mortality US 1999-2015 CSC and Prevention Morbidity Mortality - Mazur Ex 124 - 3-3-17 Malignant Meso Mortality US 1999-2015 CSC and Prevention Morbidity Mortality - Mazur ... show more |
||
| March 17, 2023 |
EXHIBIT(S) - 130 (Motion #003) Ex 130 - Madigan Dec PYoung |
||
| March 17, 2023 |
EXHIBIT(S) - 117 (Motion #003) Ex 117 - Fibrous and Mineral Content of Cosm. Talc - Cralley - Jul Aug 1968 |
||
| March 17, 2023 |
EXHIBIT(S) - 134 (Motion #003) Ex 134 - 2005_Welch, et al |
||
| March 17, 2023 |
EXHIBIT(S) - 132 (Motion #003) Ex 132 - Dxing Path Report_030620_Young_signed_Redacted |
||
| March 17, 2023 |
EXHIBIT(S) - 146 (Motion #003) Ex 146 - LANDRIGAN ET AL 1999 |
||
| March 17, 2023 |
EXHIBIT(S) - 158 (Motion #003) Ex 158 - 11-6-17 & 11-7-17 Sanchez Trial Testimony in Herford |
||
| March 17, 2023 |
EXHIBIT(S) - 104 (Motion #003) Ex 104 - 1966 Ltr from Pfizer to Customers Re Talc Coding System |
||
| March 17, 2023 |
EXHIBIT(S) - 116 (Motion #003) Ex 116 - Pfizer Tech Report 1967 |
||
| March 17, 2023 |
EXHIBIT(S) - 136 (Motion #003) Ex 136 - 1997 Helsinki |
||
| March 17, 2023 |
EXHIBIT(S) - 121 (Motion #003) Ex 121 - 12-9-83 Eval. by EM Techniques of Asb. Contamination - Paoletti |
||
| March 17, 2023 |
EXHIBIT(S) - 144 (Motion #003) Ex 144 - 2-1-77 CTFA Meeting Minutes |
||
| March 17, 2023 |
EXHIBIT(S) - 131 (Motion #003) Ex 131 - 1.6.2020 FDA Executive Summary on Talc and Asbestos |
||
| March 17, 2023 |
EXHIBIT(S) - 108 (Motion #003) Ex 108 - Ex 48 - Montana DEQ Website |
||
| March 17, 2023 |
EXHIBIT(S) - 145 (Motion #003) Ex 145 - EPA, A Guide for Ship Scrappers 2000 |
||
| March 17, 2023 |
EXHIBIT(S) - 112 (Motion #003) Ex 112 - TEM Asbestos Anaylsis of Yellowstone Ore Positive Chrysotile |
||
| March 17, 2023 |
EXHIBIT(S) - 141 (Motion #003) Ex 141 - 2017 Jiang et al |
||
| March 17, 2023 |
EXHIBIT(S) - 123 (Motion #003) Ex 123 - 10-23-84 Memo from Ashton re ASTM and ISO meetings re Paoletti paper |
||
| March 17, 2023 |
EXHIBIT(S) - 113 (Motion #003) Ex 113 - Yellowstone IH Sampling Plan |
||
| March 17, 2023 |
EXHIBIT(S) - 143 (Motion #003) Ex 143 - Keal 1960 Lancet Asbestosis And Abdominal Neoplasms (SA 0203) |
||
| March 17, 2023 |
EXHIBIT(S) - 109 (Motion #003) Ex 109 - Yellowstone - PLM analysis postive chrysotile |
||
| March 17, 2023 |
EXHIBIT(S) - 115 (Motion #003) Ex 115 - Commercial Talc Animal and Mineralogical Studies - Shultz Williams April 1942 |
||
| March 17, 2023 |
EXHIBIT(S) - 140 (Motion #003) Ex 140 - Rolland abstract (2006) |
||
| March 17, 2023 |
EXHIBIT(S) - 139 (Motion #003) Ex 139 - Rodelsperger |
||
| March 17, 2023 |
EXHIBIT(S) - 163 (Motion #003) Ex 163 - FDA Website - Cosmetics Q&A |
||
| March 17, 2023 |
EXHIBIT(S) - 127 (Motion #003) Ex 127 - Stoiber and Fitzgerald 2020 |
||
| March 17, 2023 |
EXHIBIT(S) - 129 (Motion #003) Ex 129 - Moline TT Allen |
||
| March 17, 2023 |
EXHIBIT(S) - 137 (Motion #003) Ex 137 - 2007-Welch-IJOEH-Not My Asbestos |
||
| March 17, 2023 |
EXHIBIT(S) - 135 (Motion #003) Ex 135 - 2020-05 Kanarek |
||
| March 17, 2023 |
EXHIBIT(S) - 125 (Motion #003) Ex 125 - FDA Advises Consumers to Stop Using Certain Cosmetic Products |
||
| March 17, 2023 |
EXHIBIT(S) - 126 (Motion #003) Ex 126 - 2019-10-18 FDANewsRel |
||
| March 17, 2023 |
EXHIBIT(S) - 106 (Motion #003) Ex 106 - 4-6-84 Report, Willow Creek Mine |
||
| March 17, 2023 |
EXHIBIT(S) - 107 (Motion #003) Ex 107 -1992-03-25 Munro |
||
| March 17, 2023 |
EXHIBIT(S) - 138 (Motion #003) Ex 138 - 2014 Lacourt, et al |
||
| March 17, 2023 |
EXHIBIT(S) - 122 (Motion #003) Ex 122 - 9-26-84 Letter from Ashton, J&J to Luzenac re Paoletti Paper |
||
| March 17, 2023 |
EXHIBIT(S) - 105 (Motion #003) Ex 104 - 1966 Ltr from Pfizer to Customers Re Talc Coding System |
||
| March 17, 2023 |
EXHIBIT(S) - 128 (Motion #003) Ex 128 - Cottrell 1992, Surveillance of Sentinel Occupational Mortality in DC 1980 to 1987 |
||
| March 17, 2023 |
EXHIBIT(S) - 155 (Motion #003) Ex 155 - 6-10-77 J&J Internal memo from Schelz to Task Force |
||
| March 17, 2023 |
EXHIBIT(S) - 133 (Motion #003) Ex 133 - 2016_Kanarek & Mandich |
||
| March 17, 2023 |
EXHIBIT(S) - 159 (Motion #003) Ex 159 - 9-2-16 Urbach Ross Depo in Depoian |
||
| March 17, 2023 |
EXHIBIT(S) - 162 (Motion #003) Ex 162 - 10-4-83 US Pat. 4,407,798 |
||
| March 17, 2023 |
EXHIBIT(S) - 32 (Motion #003) EX 32 - COMPTON DECLARATION w. Exhibits |
||
| March 17, 2023 |
EXHIBIT(S) - 34 (Motion #003) Ex 34 - Moline Aff - PYoung |
||
| March 17, 2023 |
EXHIBIT(S) - 16 Ex 16 - JM testing 1968 |
||
| March 17, 2023 |
EXHIBIT(S) - 10 Ex 10 - 3-5-76 Colgate lab book 6164-99 w add'l page |
||
| March 17, 2023 |
EXHIBIT(S) - 73 (Motion #003) Ex 73 - Mortality Study of Talc Miners and Millers - Rubino - March 1976 |
||
| March 17, 2023 |
EXHIBIT(S) - 19 Ex 19 - 12-10-73 Report of the CTFA Talc Subcommittee on Method to Detect Chrysotile and Tremolite i Ex 19 - 12-10-73 Report of the CTFA Talc Subcommittee on Method to Detect Chrysotile and Tremolite i ... show more |
||
| March 17, 2023 |
EXHIBIT(S) - 9 Ex 9 - 9-20-71 Colgate lab book 4044-1 |
||
| March 17, 2023 |
EXHIBIT(S) - 17 Ex 17 - 8-3-72 Letter from Lewin to Weissler |
||
| March 17, 2023 |
EXHIBIT(S) - 11 Ex 11 - 1-27-76 Colgate lab book 6164-85 |
||
| March 17, 2023 |
EXHIBIT(S) - 35 (Motion #003) Ex 35 LONGO DEC WITH EXHIBITS Ex 35 LONGO DEC WITH EXHIBITS Possible SSN Administratively Redacted |
||
| March 17, 2023 |
EXHIBIT(S) - 24 Ex 24 - 3-10-76 NYT article Asbestos found in 10 powders |
||
| March 17, 2023 |
EXHIBIT(S) - 30 Ex 30 - 1-12-76 J&J Lee memo re Pooley finds fibrous anthophyllite in CB and Coty |
||
| March 17, 2023 |
EXHIBIT(S) - 27 Ex 27 - 3-11-76 Colgate lab book 6490-2 |
||
| March 17, 2023 |
EXHIBIT(S) - 18 Ex 18 - 8-16-72 Letter from Roesch to Driscoll |
||
| March 17, 2023 |
EXHIBIT(S) - 28 Ex 28 - 8-18-17 Hopkins Depo in Herford |
||
| March 17, 2023 |
EXHIBIT(S) - 29 Ex 29 - 3-31-76 J&J Memo re Meeting with Mt Sanai |
||
| March 17, 2023 |
EXHIBIT(S) - 12 Ex 12 - 3-25-76 Colgate lab book 3-3388 |
||
| March 17, 2023 |
EXHIBIT(S) - 20 Ex 20 - 9-30-72 NYU Report |
||
| March 17, 2023 |
EXHIBIT(S) - 22 Ex 22 - 3-1-76 Memo of call between Shapiro and Langer |
||
| March 17, 2023 |
EXHIBIT(S) - 25 Ex 25 - Wash Post article Asb found in baby powder 1976 |
||
| March 17, 2023 |
EXHIBIT(S) - 21 Ex 21 - 3-22-76 Yates mtg memo |
||
| March 17, 2023 |
EXHIBIT(S) - 13 Ex 13 - 10-27-76 Colgate lab book 3-3388 |
||
| March 17, 2023 |
EXHIBIT(S) - 26 Ex 26 - Ottawa Citizen article Asbestos in talc powders dangerous 1976 |
||
| March 17, 2023 |
EXHIBIT(S) - 23 Ex 23 - 3-15-76 Letter from Costello to CTFA |
||
| March 17, 2023 |
EXHIBIT(S) - 14 Ex 14 - Letters re McCrone testing results 1976 |
||
| March 17, 2023 |
EXHIBIT(S) - 49 (Motion #003) Ex 49 - 8-6-71 Handwritten notes Amphibole minerals would be picked out |
||
| March 17, 2023 | AFFIRMATION | ||
| March 17, 2023 |
EXHIBIT(S) - 80 (Motion #003) Ex 80 - Van Gosen article |
||
| March 17, 2023 |
EXHIBIT(S) - 62 (Motion #003) Ex 62 - Draft of Mineralogy and Chem in British Talc - Pooley, Rohl, Langer |
||
| March 17, 2023 |
EXHIBIT(S) - 48 (Motion #003) Ex 48 - 4-12-60 Battelle letter |
||
| March 17, 2023 |
EXHIBIT(S) - 50 (Motion #003) Ex 50 - 8-17-17 Hopkins Depo in Herford |
||
| March 17, 2023 |
EXHIBIT(S) - 71 (Motion #003) Ex 71 - 4-12-18 Monticelli Depo in Weirick & Brick |
||
| March 17, 2023 |
EXHIBIT(S) - 79 (Motion #003) Ex 79 - Talc and Chlorite Deposits in Montana - Berg 1979 |
||
| March 17, 2023 |
EXHIBIT(S) - 63 (Motion #003) Ex 63 - 3-17-76 Langer to Chalmers |
||
| March 17, 2023 |
EXHIBIT(S) - 51 (Motion #003) Ex 51 - 1-24-68 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 74 (Motion #003) Ex 74 - Critical Reappraisal of Balangero Chrysotile and Meso Risk - Ilgren 2015 |
||
| March 17, 2023 |
EXHIBIT(S) - 52 (Motion #003) Ex 52 - 8-16-17 Hopkins Depo in Herford |
||
| March 17, 2023 |
EXHIBIT(S) - 65 (Motion #003) Ex 65 - 11-1-79 Mebus of Pfizer to S. Shope |
||
| March 17, 2023 |
EXHIBIT(S) - 81 (Motion #003) Ex 81 - Ex 24 - Olson (Pfizer) Geology of MO Talc Deposits (Abreviated) |
||
| March 17, 2023 |
EXHIBIT(S) - 72 (Motion #003) Ex 72 - J&J Memo - Worldwide Study |
||
| March 17, 2023 |
EXHIBIT(S) - 64 (Motion #003) Ex 64 - 11-9-77 McCrone Report |
||
| March 17, 2023 |
EXHIBIT(S) - 75 (Motion #003) Ex 75 - Cosmetic Talc as a Risk Factor for Pleural Meso - Inhalation Toxicology - Mirabelli 2017 |
||
| March 17, 2023 |
EXHIBIT(S) - 76 (Motion #003) Ex 76 - 11-2 and 5-18 Sanchez TT in Allen |
||
| March 17, 2023 |
EXHIBIT(S) - 86 (Motion #003) Ex 86 - JM - Talc Analysis - 399 + 12-50 Positive |
||
| March 17, 2023 |
EXHIBIT(S) - 99 (Motion #003) Ex 99 - LOC71F505-07-27-2000-BMIRegalMine-Non-Ore-Rock-Management-Vol-5 |
||
| March 17, 2023 |
EXHIBIT(S) - 82 (Motion #003) Ex 82 - Olson (Pfizer) 1976 Geology of MO Talc Deposits |
||
| March 17, 2023 |
EXHIBIT(S) - 84 (Motion #003) Ex 84 - 6-1-12 Gunter Bernard |
||
| March 17, 2023 |
EXHIBIT(S) - 83 (Motion #003) Ex 83 - 03-10-15 (Winkel)_Cond |
||
| March 17, 2023 |
EXHIBIT(S) - 53 (Motion #003) Ex 53 - 8-6-71 J&J Survey of Val Chisone |
||
| March 17, 2023 |
EXHIBIT(S) - 78 (Motion #003) Ex 78 - Asb. in Talc - Rohl - Dec 1974 |
||
| March 17, 2023 |
EXHIBIT(S) - 77 (Motion #003) Ex 77 - 3-6-14 FDA and DHHS to Pers Care Prods Council |
||
| March 17, 2023 |
EXHIBIT(S) - 100 (Motion #003) Ex 100 - LOC71F605-05-09-01-Luzenac-America-Inc-Yellowstone-Mine-Waste-Rock-Geo-Eval- |
||
| March 17, 2023 |
EXHIBIT(S) - 85 (Motion #003) Ex 85 - 1-20-16 Mulryan Depo in Dalis |
||
| March 17, 2023 |
EXHIBIT(S) - 87 (Motion #003) Ex 87- 4-6-84 - CIM Willow Creek Report |
||
| March 17, 2023 |
EXHIBIT(S) - 54 (Motion #003) Ex 54 - 9-29-71 Report of McCrone & Docs IDing Sample 2 as 1615 |
||
| March 17, 2023 |
EXHIBIT(S) - 94 (Motion #003) Ex 94 - CAMC lab reports-Depoian-000192-000193 |
||
| March 17, 2023 |
EXHIBIT(S) - 56 (Motion #003) Ex 56 - 6-12-72 ES Talc Analysis |
||
| March 17, 2023 |
EXHIBIT(S) - 88 (Motion #003) Ex 88 - 6-12-72 ES Labs Report on WCD 1736 (Treasure) |
||
| March 17, 2023 |
EXHIBIT(S) - 98 (Motion #003) Ex 98 - NATLSCO Treasure IH Study |
||
| March 17, 2023 |
EXHIBIT(S) - 55 (Motion #003) Ex 55 - 2-16-72 Certificate of Analysis, Turin Polytechnic |
||
| March 17, 2023 |
EXHIBIT(S) - 96 (Motion #003) Ex 96 - 3-2-16 & 3-3-16 Hubbard Depo in Dalis |
||
| March 17, 2023 |
EXHIBIT(S) - 97 (Motion #003) Ex 97 - 2-8-91 Pfizer Inc.s Summary of Tremolite |
||
| March 17, 2023 |
EXHIBIT(S) - 90 (Motion #003) Ex 90 - 6-12-72 ES Labs Report on WCD 399 |
||
| March 17, 2023 |
EXHIBIT(S) - 89 (Motion #003) Ex 89 - 6-12-72 ES Labs Report on WCD 1731 (Treasure) |
||
| March 17, 2023 |
EXHIBIT(S) - 92 (Motion #003) Ex 92 - Gallo depo 8-17-17 |
||
| March 17, 2023 |
EXHIBIT(S) - 95 (Motion #003) Ex 95 - July 17, 1979 Inter-Department Memo jlm |
||
| March 17, 2023 |
EXHIBIT(S) - 93 (Motion #003) Ex 93 - Memo Shepich to Wilson 10-2-78 |
||
| March 17, 2023 |
EXHIBIT(S) - 91 (Motion #003) Ex 91 - 6-12-72 ES Labs Report on WCD 1745 |
||
| March 17, 2023 |
EXHIBIT(S) - 102 (Motion #003) Ex 102 - 10-6-77 Ltr re customers finding tremolite in MT + CA Pfizer talc |
||
| March 17, 2023 |
EXHIBIT(S) - 57 (Motion #003) Ex 57 - TEM 2011 Yellowstone Chrysotile |
||
| March 17, 2023 |
EXHIBIT(S) - 103 (Motion #003) Ex 103 - 12-14-79 Pfizer Memo re Montana Talc Asbestos |
||
| March 17, 2023 |
EXHIBIT(S) - 110 (Motion #003) Ex 110 - RJL Yellowstone Chrysotile Asbestos Finding |
||
| March 17, 2023 |
EXHIBIT(S) - 101 (Motion #003) Ex 101 - 9-76 - Routine Analysis of Pfizer Talc |
||
| March 17, 2023 |
EXHIBIT(S) - 160 (Motion #003) Ex 160 - 10-15-62 J&J Product Improvement, New Product Dev. Memo |
||
| March 17, 2023 |
EXHIBIT(S) - 157 (Motion #003) Ex 157 - FDA Protecting and Promoting Your Health |
||
| March 17, 2023 |
EXHIBIT(S) - 151 (Motion #003) Ex 151 - 10-7-76 CTFA Method J4-1 |
||
| March 17, 2023 |
EXHIBIT(S) - 156 (Motion #003) Ex 156 - 3-18-76 FDA Memo |
||
| March 17, 2023 |
EXHIBIT(S) - 4 Colgate Resp. to Std Rogs in Polakow |
||
| March 17, 2023 |
EXHIBIT(S) - 1 Young Disc Resp |
||
| March 17, 2023 |
EXHIBIT(S) - 5 4-16-15 Capdevielle trial testimony in Winkel |
||
| March 17, 2023 |
EXHIBIT(S) - 36 (Motion #003) Ex 36 - 2020 Steffen et al 'Serous Ovar' |
||
| March 17, 2023 |
EXHIBIT(S) - 39 (Motion #003) Ex 39 - Scala Dep 20160720 |
||
| March 17, 2023 |
EXHIBIT(S) - 38 (Motion #003) Ex 38 - Colgate objections and resp to P's Suppl Rogs in Schoeniger |
||
| March 17, 2023 |
EXHIBIT(S) - 37 (Motion #003) Ex 37 - Colgate resp to RFA in Polakow |
||
| March 17, 2023 |
EXHIBIT(S) - 58 (Motion #003) Ex 58 - 9-8-72 Pooley Report of Italian Talc Source Mine |
||
| March 17, 2023 |
EXHIBIT(S) - 43 (Motion #003) Ex 43 - 7-31-59 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 42 (Motion #003) Ex 42 - 5-9-58 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 41 (Motion #003) Ex 40 - 10-15-57 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 41 (Motion #003) Ex 41 - 5-23-58 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 66 (Motion #003) Ex 66 - Geology and Genesis of Talc Deposits in Pinerolese - Peretti 1966 |
||
| March 17, 2023 |
EXHIBIT(S) - 46 (Motion #003) Ex 46 - 12-31-59 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 45 (Motion #003) Ex 45 - 9-15-59 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 59 (Motion #003) Ex 59 - 12-8-72 Stanley of Pfizer Rpt to Clements of Coty |
||
| March 17, 2023 |
EXHIBIT(S) - 44 (Motion #003) Ex 44 - 8-31-59 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 61 (Motion #003) Ex 61 - 11-19-73 Pooley Analysis of VT and Italian Talc |
||
| March 17, 2023 |
EXHIBIT(S) - 60 (Motion #003) Ex 60 - 8-28-73 Internal JM Memo re Determination of Chrysotile by TEM |
||
| March 17, 2023 | STATEMENT OF MATERIAL FACTS | ||
| March 17, 2023 |
EXHIBIT(S) - 69 (Motion #003) Ex 69 - 9-23-11 Lehman Depo in Bernard & Konopka |
||
| March 17, 2023 |
EXHIBIT(S) - 68 (Motion #003) Ex 68 - 9-8-11 Lehman Depo in Bernard & Konopka |
||
| March 17, 2023 |
EXHIBIT(S) - 67 (Motion #003) Ex 67 - 5-15-84 Memo from Olson of Cyprus |
||
| March 17, 2023 |
EXHIBIT(S) - 70 (Motion #003) Ex 70 - 5-20-14 Lehman Depo in Diaz & Fishbain |
||
| March 17, 2023 |
EXHIBIT(S) - 147 (Motion #003) Ex 147 - 027 Hillerdal 1999 |
||
| March 17, 2023 |
EXHIBIT(S) - 154 (Motion #003) Ex 154 - 3-31-77 J&J Internal memo from Schelz to Estrin |
||
| March 17, 2023 | MEMORANDUM OF LAW IN REPLY | ||
| March 17, 2023 |
EXHIBIT(S) - 118 (Motion #003) Ex 118 - 8-13-71 CSOM baby powder eval |
||
| March 17, 2023 |
EXHIBIT(S) - 47 (Motion #003) Ex 47 - 3-8-60 Battelle |
||
| March 17, 2023 |
EXHIBIT(S) - 148 (Motion #003) Ex 148 - Iwatsubo Y., Pleural Meso, Dose Response in French Population, 1998 |
||
| March 17, 2023 |
EXHIBIT(S) - 119 (Motion #003) Ex 119 - ID and Quant of Asb in Talc - Rohl, Langer - Dec 1974 |
||
| March 17, 2023 |
EXHIBIT(S) - 153 (Motion #003) Ex 153 - 12-20-73 Ltr Ronald Draftz |
||
| March 17, 2023 |
EXHIBIT(S) - 152 (Motion #003) Ex 152 - 7-7-16 Weiss Depo in Polakow |
||
| March 17, 2023 |
EXHIBIT(S) - 149 (Motion #003) Ex 149 - OSHA website |
||
| March 17, 2023 |
EXHIBIT(S) - 150 (Motion #003) Ex 150 - 8-15-17 Hopkins Depo in Herford |
||
| March 17, 2023 |
EXHIBIT(S) - 161 (Motion #003) Ex 161 - 5-15-72 International Technical Service Manufacturing Letter |
||
| March 03, 2023 |
EXHIBIT(S) - 22 (Motion #003) Capdevielle Depo 10/5/10 |
||
| March 03, 2023 |
EXHIBIT(S) - 24 (Motion #003) DaSalva Depo 3/18/11 |
||
| March 03, 2023 |
EXHIBIT(S) - 28 (Motion #003) Simko letter |
||
| March 03, 2023 |
EXHIBIT(S) - 25 (Motion #003) Turse Depo 11/10/12 |
||
| March 03, 2023 |
EXHIBIT(S) - 23 (Motion #003) Simko Depo 1/21/11 |
||
| March 03, 2023 |
EXHIBIT(S) - 31 (Motion #003) FDA Study 1973 (Lewin) |
||
| March 03, 2023 |
EXHIBIT(S) - 35 (Motion #003) Ohlmeyer Depo 4-11-11 |
||
| March 03, 2023 |
EXHIBIT(S) - 32 (Motion #003) Yates memo |
||
| March 03, 2023 |
EXHIBIT(S) - 30 (Motion #003) RMPS 2 |
||
| March 03, 2023 |
EXHIBIT(S) - 33 (Motion #003) Schwartz 1-10-12 |
||
| March 03, 2023 |
EXHIBIT(S) - 34 (Motion #003) Briscese 10-26-10 |
||
| March 03, 2023 |
NOTICE OF MOTION (Motion #002) Insight Pharmaceuticals LLC |
||
| March 03, 2023 |
EXHIBIT(S) - 3 (Motion #003) Pltf Interrogatory Responses Redacted per 22 NYCRR Pltf Interrogatory Responses Redacted |
||
| March 03, 2023 |
EXHIBIT(S) - 8 (Motion #003) Sahmel Affidavit |
||
| March 03, 2023 |
EXHIBIT(S) - 2 (Motion #003) Colgate's Answer |
||
| March 03, 2023 |
EXHIBIT(S) - 9 (Motion #003) Weill Affidavit |
||
| March 03, 2023 |
EXHIBIT(S) - 4 (Motion #003) Discovery Deposition of Patsy Young Redacted per 22 NYCRR Discovery Deposition of Patsy Young Redacted |
||
| March 03, 2023 |
EXHIBIT(S) - P (Motion #002) U.S. Patent & Trademark Office's Trademark Assignment Abstract of Title on the Caldesene Mark |
||
| March 03, 2023 |
EXHIBIT(S) - 7 (Motion #003) Burke Affidavit |
||
| March 03, 2023 |
EXHIBIT(S) - 6 (Motion #003) Note of Issue |
||
| March 03, 2023 |
EXHIBIT(S) - 5 (Motion #003) De Bene Esse Deposition |
||
| March 03, 2023 |
EXHIBIT(S) - O (Motion #004) Pira, Mortality of Talc Miners & Millers in Italy (2017) |
||
| March 03, 2023 |
EXHIBIT(S) - 1 (Motion #003) Complaint and Fact Sheet |
||
| March 03, 2023 |
EXHIBIT(S) - T (Motion #004) World Health Org., Int'l Agency for Research on Cancer |
||
| March 03, 2023 |
EXHIBIT(S) - P (Motion #004) 2-28-23 Expert Report of Christy Barlow |
||
| March 03, 2023 |
EXHIBIT(S) - R (Motion #004) US Dept. of Health & Human Svc, Qualitative Risk Assessment Committee |
||
| March 03, 2023 |
EXHIBIT(S) - Q (Motion #004) FDA Memorandum of Heinz Eiermann, Dir. Div. of Cosmetics Technology |
||
| March 03, 2023 |
EXHIBIT(S) - L (Motion #004) Rubino - Mortality & Morbidity Among Talc Miners & Milers in Italy |
||
| March 03, 2023 |
EXHIBIT(S) - N (Motion #004) Coggolia, An Update of a Mortality Study of Talc (2003) |
||
| March 03, 2023 |
EXHIBIT(S) - S (Motion #004) FDA Ltr by J.W. Swanson, Acting Assoc. Commissioner for Regulatory Affairs, FDA |
||
| March 03, 2023 |
EXHIBIT(S) - H (Motion #004) WCD Sales Record to Chattem |
||
| March 03, 2023 |
EXHIBIT(S) - V (Motion #004) IARC World Health Org., Int'l Agency for Research on Cancer |
||
| March 03, 2023 |
EXHIBIT(S) - U (Motion #004) Copy of US Dept of Health & Human Svc, Report on Talc Workshop |
||
| March 03, 2023 |
EXHIBIT(S) - HH (Motion #004) Grunert (1st Dept.) |
||
| March 03, 2023 |
EXHIBIT(S) - W (Motion #004) Shields v. American Biltrite Inc. Index# 2016-3854 |
||
| March 03, 2023 |
EXHIBIT(S) - D (Motion #001) Exhibit D - Compiled Deposition Transcripts |
||
| March 03, 2023 |
EXHIBIT(S) - A (Motion #001) Exhibit A - Plaintiffs Complaint |
||
| March 03, 2023 |
EXHIBIT(S) - B (Motion #001) Exhibit B - CBC's Answer |
||
| March 03, 2023 |
NOTICE OF MOTION (Motion #001) CBC's Notice of Motion for MSJ |
||
| March 03, 2023 | MEMORANDUM OF LAW IN SUPPORT | ||
| March 03, 2023 |
EXHIBIT(S) - 21 (Motion #003) Formula Cards |
||
| March 03, 2023 |
EXHIBIT(S) - A (Motion #004) Summons and Complaint |
||
| March 03, 2023 |
EXHIBIT(S) - 43 (Motion #003) Diette Affidavit |
||
| March 03, 2023 |
EXHIBIT(S) - PP (Motion #004) Copy of Dr. Moline's Sworn Dep Testimony - 10.16.2014 |
||
| March 03, 2023 |
EXHIBIT(S) - 36 (Motion #003) Lyons Order |
||
| March 03, 2023 |
EXHIBIT(S) - NN (Motion #004) McNeal v. WCD |
||
| March 03, 2023 |
EXHIBIT(S) - 42 (Motion #003) Longo 9-26-18 |
||
| March 03, 2023 |
AFFIDAVIT OR AFFIRMATION IN SUPPORT OF MOTION (Motion #004) Affirmation of Christopher Kozak in Support |
||
| March 03, 2023 |
EXHIBIT(S) - 40 (Motion #003) Nemeth Order |
||
| March 03, 2023 |
EXHIBIT(S) - 41 (Motion #003) Longo 9-28-18 |
||
| March 03, 2023 |
EXHIBIT(S) - 37 (Motion #003) Stevenson Order |
||
| March 03, 2023 |
EXHIBIT(S) - II (Motion #004) Olson (1st Dept.) |
||
| March 03, 2023 |
NOTICE OF MOTION (Motion #004) Notice of Motion for Summary Judgment |
||
| March 03, 2023 |
EXHIBIT(S) - S (Motion #002) OTC Drug Review Process |
||
| March 03, 2023 |
EXHIBIT(S) - O (Motion #002) Declaration of Michael Westhusing |
||
| March 03, 2023 |
EXHIBIT(S) - M (Motion #002) Drug Applications for Over-the-Counter (OTC) Drugs |
||
| March 03, 2023 |
EXHIBIT(S) - A (Motion #002) Plaintiff's Answers to Interrogatories (1.21.21) Redacted per 22 NYCRR Plaintiff's Answers to Interrogatories (1.21.21) Redacted |
||
| March 03, 2023 |
EXHIBIT(S) - C (Motion #002) Condensed transcript of Plaintiff's de bene esse examination Redacted per 22 NYCRR Condensed transcript of Plaintiff's de bene esse examination Redacted |
||
| March 03, 2023 |
EXHIBIT(S) - K (Motion #002) Relevant excerpts from dep. of Sean Fitzgerald in Winkel v. Calaveras Asbestos Ltd., et al. (3.17.15 Relevant excerpts from dep. of Sean Fitzgerald in Winkel v. Calaveras Asbestos Ltd., et al. (3.17.15 ... show more |
||
| March 03, 2023 |
EXHIBIT(S) - R (Motion #002) FDA Summary of Results from Testing |
||
| March 03, 2023 |
EXHIBIT(S) - L (Motion #002) Talc Monograph from US Pharmocopeia |
||
| March 03, 2023 |
EXHIBIT(S) - N (Motion #002) Letter from Mitchell to Johnson (5.7.12) |
||
| March 03, 2023 |
EXHIBIT(S) - T (Motion #002) Over-the-Counter Monograph M016 |
||
| March 03, 2023 |
EXHIBIT(S) - E (Motion #002) Insight's Responses to Plaintiff's Supplemental Interrogatories and Requests for Production |
||
| March 03, 2023 | AFFIDAVIT OR AFFIRMATION IN SUPPORT OF MOTION | ||
| March 03, 2023 |
EXHIBIT(S) - Q (Motion #002) Relevant excerpts from video dep. of Jean Boyko in Schnacke v. 3M |
||
| March 03, 2023 |
NOTICE OF MOTION (Motion #003) Colgate-Palmolive Company's Motion for Summary Judgment |
||
| March 03, 2023 |
EXHIBIT(S) - C (Motion #001) Exhibit C - Redacted Answers to Interrogatories |
||
| March 03, 2023 |
AFFIDAVIT OR AFFIRMATION IN SUPPORT (Motion #002) Attorney Affirmation of Robert J. Mullins, II |
||
| March 03, 2023 |
AFFIDAVIT OR AFFIRMATION IN SUPPORT OF MOTION (Motion #001) CBC's Attorney Affirmation in support of Motion for MSJ |
||
| March 03, 2023 |
MEMORANDUM OF LAW IN SUPPORT (Motion #001) CBC's Memo of Law in Support of Motion |
||
| March 03, 2023 |
EXHIBIT(S) - G (Motion #002) Affidavit of Jean Boyko (5.9.22) |
||
| March 03, 2023 |
EXHIBIT(S) - B (Motion #002) Condensed Deposition Transcripts of Plaintiff Redacted per 22 NYCRR Condensed Deposition Transcripts of Plaintiff Redacted |
||
| March 03, 2023 |
EXHIBIT(S) - D (Motion #002) Correspondence from S. Kerley (1.13.22) with service of Pltf's Supplemental Demands |
||
| March 03, 2023 |
EXHIBIT(S) - H (Motion #002) Letter from J.W. Swanson to P. Douillet (7.11.86) |
||
| March 03, 2023 |
CERTIFICATION OF SIGNATURE ( ATTORNEY OR PARTY ) (Motion #001) CBC's Attorney Certification |
||
| March 03, 2023 |
EXHIBIT(S) - F (Motion #002) Affidavit of Alan M. Segrave, P.G. (1.30.23) |
||
| March 03, 2023 |
ORDER ( PROPOSED ) (Motion #001) CBC's Proposed Order Granting MSJ |
||
| March 03, 2023 |
EXHIBIT(S) - I (Motion #004) Signed General Affidavit by Alan Segrave |
||
| March 03, 2023 |
EXHIBIT(S) - Y (Motion #004) Copy of Wagner v. Bondex Int'l Inc. |
||
| March 03, 2023 |
EXHIBIT(S) - LL (Motion #004) Excerpts of Trial Ruling in the Robusto (2015) & Nemeth (2017) |
||
| March 03, 2023 |
EXHIBIT(S) - K (Motion #004) Rubino, et al. - Morality Studies of Talc Miners & Millers (1976) |
||
| March 03, 2023 |
EXHIBIT(S) - X (Motion #004) Copy of Collin v. Calportland Co. |
||
| March 03, 2023 |
EXHIBIT(S) - OO (Motion #004) FDA August 3, 1971 Symposium on Talc |
||
| March 03, 2023 |
EXHIBIT(S) - 39 (Motion #003) Nemeth 3-28-17 |
||
| March 03, 2023 |
EXHIBIT(S) - C (Motion #004) Plaintiff's Answers to Interrogatories |
||
| March 03, 2023 |
EXHIBIT(S) - M (Motion #004) Wild, A Cohort Mortality & Nested Case - Control Study (2002) |
||
| March 03, 2023 |
EXHIBIT(S) - J (Motion #004) Signed General Affidavit by Kenneth Mundt |
||
| March 03, 2023 |
MEMORANDUM OF LAW IN SUPPORT (Motion #004) Memorandum of Law in Support |
||
| March 03, 2023 |
EXHIBIT(S) - G (Motion #004) WCD Sales Record to Block Drug |
||
| March 03, 2023 |
EXHIBIT(S) - JJ (Motion #004) Justice Heitler Decision |
||
| March 03, 2023 |
EXHIBIT(S) - 38 (Motion #003) Alfaro 6-15-16 |
||
| March 03, 2023 |
EXHIBIT(S) - Z (Motion #004) Copy of Lindstrom v. AC Product Liability Trust |
||
| March 03, 2023 |
EXHIBIT(S) - D (Motion #004) Plaintiff's Dep Transcript |
||
| March 03, 2023 |
STATEMENT OF MATERIAL FACTS (Motion #004) Statement of Material Facts |
||
| March 03, 2023 |
EXHIBIT(S) - CC (Motion #004) Copy of Hanson v. Colgate-Palmolive Co. |
||
| March 03, 2023 |
EXHIBIT(S) - E (Motion #004) WCD Sales Record to Avon |
||
| March 03, 2023 |
EXHIBIT(S) - EE (Motion #004) See in Re NYC Asbestos Litigation |
||
| March 03, 2023 |
EXHIBIT(S) - DD (Motion #004) Nemeth v. Brenntag N. Am. |
||
| March 03, 2023 |
EXHIBIT(S) - BB (Motion #004) Copy of Berg v. Alta Bldg Material Co. |
||
| March 03, 2023 |
EXHIBIT(S) - B (Motion #004) WCD's Verified Answer |
||
| March 03, 2023 |
EXHIBIT(S) - KK (Motion #004) Justice Molton Decision |
||
| March 03, 2023 |
EXHIBIT(S) - MM (Motion #004) Donovan v. A.O. Smith Water Products Co. |
||
| March 03, 2023 |
EXHIBIT(S) - F (Motion #004) WCD Sales Records to Gold Bond |
||
| March 03, 2023 |
EXHIBIT(S) - FF (Motion #004) Pomponi (1st Dept) |
||
| March 03, 2023 |
EXHIBIT(S) - GG (Motion #004) Dyer (1st Dept.) |
||
| March 03, 2023 |
EXHIBIT(S) - AA (Motion #004) Copy of Chap v. Borg-Warner Morse Tec LLC |
||
| March 03, 2023 |
EXHIBIT(S) - J (Motion #002) 2010 FDA Survey of Talc in Cosmetics |
||
| March 03, 2023 |
EXHIBIT(S) - 11 (Motion #003) Rubino 1976 |
||
| March 03, 2023 |
EXHIBIT(S) - 17 (Motion #003) Madar Order |
||
| March 03, 2023 |
EXHIBIT(S) - I (Motion #002) Memo from Dr. Alfred Wiessler to Robert M. Shaffner (7.31.73) |
||
| March 03, 2023 |
EXHIBIT(S) - 13 (Motion #003) Coggiola 2003 |
||
| March 03, 2023 |
EXHIBIT(S) - 14 (Motion #003) Pira 2017 |
||
| March 03, 2023 |
EXHIBIT(S) - 12 (Motion #003) Rubino 1979 |
||
| March 03, 2023 |
EXHIBIT(S) - 10 (Motion #003) Zhang Depo 8/30/18 |
||
| March 03, 2023 | STATEMENT OF MATERIAL FACTS | ||
| March 03, 2023 |
EXHIBIT(S) - 15 (Motion #003) Ciocan 2021 |
||
| March 03, 2023 |
EXHIBIT(S) - 19 (Motion #003) Barlow Order |
||
| March 03, 2023 |
EXHIBIT(S) - 26 (Motion #003) Ohlmeyer Depo 1 |
||
| March 03, 2023 |
EXHIBIT(S) - 16 (Motion #003) Moline Depo 10/16/14 |
||
| March 03, 2023 |
EXHIBIT(S) - 18 (Motion #003) Citizens Petition 1986 |
||
| March 03, 2023 |
EXHIBIT(S) - 29 (Motion #003) Capdevielle Depos (2009, 2010) |
||
| March 03, 2023 |
EXHIBIT(S) - 20 (Motion #003) Black v Brenntag |
||
| March 03, 2023 |
EXHIBIT(S) - 27 (Motion #003) RMPS |
||
| February 08, 2023 |
ORDER - CASE SCHEDULING 3RD AMENDED |
||
| January 31, 2023 |
PRE-TRIAL DOCUMENT(S) Plaintiff's Exhibit List, Trial Witness List & Expert Reliance Materials |
||
| January 27, 2023 |
ORDER ( PROPOSED ) Proposed 3rd Amended Scheduling Order, TD = 5/23/2023 Proposed 3rd Amended Scheduling Order, TD = 5/23/2023 Possible SSN Administratively Redacted |
||
| January 18, 2023 |
NOTE OF ISSUE:WITH JURY Note of Issue |
||
| October 26, 2022 |
ORDER - CASE SCHEDULING SECOND AMENDED |
||
| October 13, 2022 |
ORDER ( PROPOSED ) Proposed 2nd Amended Discovery and Trial Scheduling Order |
||
| July 28, 2022 |
STIPULATION - SO ORDERED CONFIDENTIALITY |
||
| July 18, 2022 |
STIPULATION - DISCOVERY ( REQUEST TO SO ORDER ) with Exhibit A attached |
||
| July 14, 2022 | STIPULATION - CONFIDENTIALITY ( REQUEST TO SO ORDER ) | ||
| June 24, 2022 |
STIPULATION - DISCONTINUANCE (POST RJI) Stipulation of Discontinuance with Prejudice as to Avon Products, Inc. |
||
| June 13, 2022 | Notice of Entry of Order of Dismissal as to Defendant GlaxoSmithKline LLC | ||
| June 13, 2022 | Notice of Entry of Order of Dismissal as to Defendant GSK Consumer Health LLC | ||
| June 13, 2022 | Notice of Entry of Order of Dismissal as to Defendant Block Drug Corporation | ||
| June 11, 2022 |
ORDER - DISMISSAL de: Glaxosmithkline LLC |
||
| June 11, 2022 |
ORDER - DISMISSAL de: GSK Consumer Health Inc. |
||
| June 11, 2022 |
ORDER - DISMISSAL de: Block Drug Corporation |
||
| June 07, 2022 |
ORDER ( PROPOSED ) Proposed Order of Dismissal as to Block Drug Corporation |
||
| June 07, 2022 |
ORDER ( PROPOSED ) Proposed Order of Dismissal as to GlaxoSmithKline, LLC |
||
| June 07, 2022 |
ORDER ( PROPOSED ) Proposed Order of Dismissal as to GSK Consumer Health LLC |
||
| June 06, 2022 |
STIPULATION - PARTIAL DISCONTINUANCE (POST RJI) Stipulation of Discontinuance with Prejudice as to GSK Consumer Health LLC |
||
| June 06, 2022 |
STIPULATION - PARTIAL DISCONTINUANCE (POST RJI) Stipulation of Discontinuance without Prejudice as to GlaxosmithKline, LLC |
||
| June 06, 2022 |
STIPULATION - PARTIAL DISCONTINUANCE (POST RJI) Stipulation of Discontinuance without Prejudice as to Defendant Block Drug Corporation |
||
| April 21, 2022 | CONSENT TO CHANGE ATTORNEY (POST RJI) | ||
| March 23, 2022 |
ORDER - TRIAL SCHEDULING Amended Discovery Order & Trial Scheduling Order |
||
| March 23, 2022 |
EXHIBIT(S) - B Discovery & Trial Submission Schedule |
||
| March 23, 2022 |
EXHIBIT(S) - A Discovery & Trial Submission Schedule |
||
| January 18, 2022 |
PRE-TRIAL DOCUMENT(S) Notice of Intent to Offer Public Records at Trial |
||
| January 13, 2022 |
ORDER (PROPOSED) (AMENDED) Amended Discovery & Trial Order for signature - JS 9/27/2022 |
||
| January 13, 2022 |
EXHIBIT(S) - B Amended Discovery & Trial Submission Schedule - JS 9/27/2022 |
||
| January 13, 2022 |
EXHIBIT(S) - A Initial Discovery & Trial Submission Schedule - JS 2/1/2022 |
||
| January 03, 2022 |
ORDER - DISMISSAL de: Macy's Inc. |
||
| January 03, 2022 | NOTICE OF ENTRY | ||
| January 03, 2022 |
EXHIBIT(S) - A Order re Macy's, Inc. |
||
| December 22, 2021 | LETTER / CORRESPONDENCE TO JUDGE | ||
| December 22, 2021 | STIPULATION - DISCONTINUANCE (POST RJI) | ||
| December 22, 2021 |
ORDER ( PROPOSED ) Macy's, Inc. |
||
| October 18, 2021 |
ANSWER WITH CROSS-CLAIM(S) Answer of Charles B. Chrystal Company, Inc. |
||
| September 02, 2021 | Affidavit of Service - Himmel - Third Party Complaint | ||
| August 20, 2021 |
RESPONSE TO DEMAND Objections and Answers to Plaintiffs Supplemental Interrogatories and Requests for Production of Doc Objections and Answers to Plaintiffs Supplemental Interrogatories and Requests for Production of Doc ... show more |
||
| August 09, 2021 |
NOTICE OF ENTRY Novartis Corporation and Novartis Pharmaceuticals Corporation's Notice of Entry of Dismissal Order |
||
| August 09, 2021 |
ORDER - DISMISSAL de: Novartis Corp. & Novartis Pharmaceuticals Corp. |
||
| August 04, 2021 |
ORDER ( PROPOSED ) Novartis/NPC Proposed Order of Dismissal (Requested 7/14/21 Doc. No. 31) |
||
| July 26, 2021 |
NOTICE OF DEPOSITION UPON ORAL EXAMINATION Colgate-Palmolive Company's Adjournment of Deposition of Patricia Foreman |
||
| July 26, 2021 | Affidavit of Service - Himmel Media LLC | ||
| July 22, 2021 |
LETTER / CORRESPONDENCE TO JUDGE Colgate-Palmolive Company - Stay of Proceeding Against Insureds of Bedivere |
||
| July 14, 2021 |
DEMAND FOR: Novartis Corporation and Novartis Pharmaceuticals Corporation request for Execution of Dismissal Ord Novartis Corporation and Novartis Pharmaceuticals Corporation request for Execution of Dismissal Ord ... show more |
||
| July 14, 2021 |
EXHIBIT(S) - A Novartis Corporation and Novartis Pharmaceuticals Corporation's Stipulation of Discontinuance |
||
| July 14, 2021 |
LETTER / CORRESPONDENCE TO JUDGE Novartis Corporation and Novartis Pharmaceuticals Corporation's Letter requesting Dismissal |
||
| July 12, 2021 |
STIPULATION - DISCONTINUANCE (POST RJI) Novartis Corporation and Novartis Pharmaceuticals Corporation's Stipulation of Discontinuance |
||
| June 23, 2021 |
DEMAND FOR: Product Identification Letter o/b/o Macy's, Inc. |
||
| June 17, 2021 | THIRD PARTY SUMMONS/COMPLAINT | ||
| March 19, 2021 |
ANSWER Block Drug's Verified Answer to Verified Complaint |
||
| March 19, 2021 |
ANSWER GSK Consumer Health's Verified Answer to Verified Complaint |
||
| March 19, 2021 |
ANSWER GSK LLC's Verified Answer to Verified Complaint |
||
| March 19, 2021 |
EXHIBIT(S) - A Discovery & Trial Submission Schedule |
||
| March 19, 2021 | ORDER - TRIAL SCHEDULING | ||
| March 17, 2021 |
ORDER ( PROPOSED ) Discovery & Trial Order for signature - JS 2/1/2022 |
||
| March 17, 2021 |
EXHIBIT(S) - A Discovery & Trial Submission Schedule - JS 2/1/2022 |
||
| March 04, 2021 | ANSWER | ||
| March 02, 2021 |
ANSWER WITH CROSS-CLAIM(S) Colgate-Palmolive Company's Verified Answer |
||
| March 01, 2021 | STIPULATION - DISCONTINUANCE (POST RJI) | ||
| February 18, 2021 |
ANSWER WITH CROSS-CLAIM(S) Defendant Avon Products, Inc.'s Verified Answer to Plaintiff's Complaint |
||
| February 14, 2021 | NOTICE OF BANKRUPTCY (POST RJI) | ||
| February 12, 2021 |
ANSWER Sanofi |
||
| February 12, 2021 |
ANSWER Chattem |
||
| February 12, 2021 |
ANSWER Sanofi-Aventis |
||
| February 12, 2021 |
ANSWER Aventis |
||
| January 26, 2021 | AFFIRMATION/AFFIDAVIT OF SERVICE | ||
| January 26, 2021 | DEMAND FOR: | ||
| January 26, 2021 | ANSWER WITH CROSS-CLAIM(S) | ||
| January 25, 2021 | ANSWER WITH CROSS-CLAIM(S) | ||
| January 12, 2021 |
ANSWER WITH CROSS-CLAIM(S) Answer to Complaint - CYPRUS MINES CORPORATION |
||
| January 12, 2021 |
ANSWER WITH CROSS-CLAIM(S) Answer to Complaint - CYPRUS AMAX MINERALS COMPANY |
||
| December 10, 2020 |
EXHIBIT(S) - A Plaintiff's Statement |
||
| December 10, 2020 | ADDENDUM - GENERAL (840A) | ||
| December 10, 2020 | RJI -RE: REQUEST FOR PRELIMINARY CONFERENCE | ||
| December 10, 2020 | SUMMONS + COMPLAINT |
